InVivo Therapeutics Holdings Corp.

One Kendall Square, Suite B14402

Cambridge, MA 02139

 

June 2, 2020

 

VIA EDGAR

 

Securities and Exchange Commission

Division of Corporation Finance

100 F Street, N.E.

Washington, D.C. 20549

 

Re:         InVivo Therapeutics Holdings Corp.

Registration Statement on Form S-1

File No. 333-238635

Request for Acceleration

 

Ladies and Gentlemen:

 

Pursuant to Rule 461 promulgated under the Securities Act of 1933, as amended, InVivo Therapeutics Holdings Corp. hereby requests acceleration of the effective date of its Registration Statement on Form S-1 (File No. 333-238635), so that it may become effective at 4:00 p.m. on June 4, 2020, or as soon thereafter as practicable.

 

 

[Remainder of Page Intentionally Left Blank]

 

 

 

 

  Very truly yours,
   
   
  INVIVO THERAPEUTICS HOLDINGS
  CORP.
   
  By: /s/ Richard Toselli
  Name: Richard Toselli
  Title: President and Chief Executive Officer

 

Signature Page to Acceleration Request